<?xml version="1.0" encoding="UTF-8"?>
<ref id="B186">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Yousfi</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Cassagne</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Ranque</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Rolain</surname>
    <given-names>J.-M.</given-names>
   </name>
   <name>
    <surname>Bittar</surname>
    <given-names>F.</given-names>
   </name>
  </person-group> (
  <year>2019</year>). 
  <article-title>Repurposing of ribavirin as an adjunct therapy against invasive candida strains in an in vitro study.</article-title>
  <source>
   <italic>Antimicrob. Agents Chemother.</italic>
  </source>
  <volume>63</volume>:
  <issue>e00263-19</issue>. 
  <pub-id pub-id-type="doi">10.1128/AAC.00263-19</pub-id>
  <?supplied-pmid 31307986?>
  <pub-id pub-id-type="pmid">31307986</pub-id>
 </mixed-citation>
</ref>
